{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113484","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.691744+00:00","generated_at":"2026-05-30T07:02:04.718480+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Secondary offering of 8M shares by certain shareholders; company receives no proceeds","bullets":["Selling Shareholders sold 8,000,000 shares of common stock in a registered public offering.","Underwriters granted a 30-day option to purchase up to 1,200,000 additional shares.","J.P. Morgan Securities LLC acted as the sole underwriter for the offering.","Company will not receive any proceeds from the sale; all net proceeds go to Selling Shareholders.","Offering closed on November 1, 2024, under an Underwriting Agreement dated October 30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113484","json":"https://secwatch.observer/filing/0001104659-24-113484.json","markdown":"https://secwatch.observer/filing/0001104659-24-113484.md","text":"https://secwatch.observer/filing/0001104659-24-113484.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000110465924113484/0001104659-24-113484-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000110465924113484/tm2427273d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:02:04.718480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}